NOVORIDGE is a leading chemistry focused CRO company specialized in small molecule drug discovery services to accelerate your drug discovery and development program.

NOVORIDGE is a leading Chemistry CRO in radiopharmaceutical and theranostics precursors development services, support you to accelerate your radiopharmaceuticals and theranostics drug development efforts.

Novoridge is chemistry focused CRO organisation and provide innovative drug discovery services to leading pharmaceutical companies, including biotech firms, and academic institutions through our location in India and Korea.

Employing in silico methods in drug development helps toward identification of potent hits and lead molecules thereby reducing the risk of late-stage clinical failures.

We manufacture and supply a diverse range of fine and specialty chemicals, catering to industries such as pharmaceuticals, nutraceuticals, agrichemicals, cosmetics, fragrances, flavors, and other specialty markets.

Targeted protein degradation (TPD) refers to the deliberate breakdown of specific proteins within cells.

Novoridge is dedicated to providing chemistry-focused antibody-drug conjugate (ADC) development services to the biotech and pharmaceutical industries.

At Novoridge, our expertise in medicinal and computational chemistry elevates small molecule discovery to the next level. Leveraging proprietary methods, we rapidly screen thousands of compounds, with facilitating knowledge-driven design and synthesis.